GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM33605
Query DataSets for GSM33605
Status
Public on Oct 30, 2004
Title
wt control hybA
Sample type
RNA
Source name
danio rerio control morpholino
Organism
Danio rerio
Extracted molecule
total RNA
Description
total RNA derived from danio rerio control morpholino
Submission date
Oct 27, 2004
Last update date
May 27, 2005
Contact name
Henning Witt
E-mail(s)
witt@molgen.mpg.de
Phone
++49-30-450578727
Organization name
Max Planck Institute for Molecular Genetics
Department
Hans Lehrach
Lab
Patricia Ruiz
Street address
Ihnestrasse 65
City
Berlin
ZIP/Postal code
14195
Country
Germany
Platform ID
GPL1319
Series (1)
GSE1894
nck2 vs. wt morpholino
Data table header descriptions
ID_REF
VALUE
normalized intenssity
SIGNAL_RAW
raw intensity
DETECTION P-VALUE
detection p-value
Data table
ID_REF
VALUE
SIGNAL_RAW
DETECTION P-VALUE
AFFX-BioB-3_at
1119.8
44.8
0.01667
AFFX-BioB-5_at
1907.1
76.3
0.003212
AFFX-BioB-M_at
2159.5
86.4
0.000446
AFFX-BioC-3_at
2172
86.9
0.000147
AFFX-BioC-5_at
3734.2
149.4
0.000127
AFFX-BioDn-3_at
16728.9
669.3
0.000127
AFFX-BioDn-5_at
2861.9
114.5
0.000044
AFFX-CreX-3_at
52281.2
2091.7
0.000044
AFFX-CreX-5_at
33195.3
1328.1
0.00006
AFFX-DapX-3_at
40
1.6
0.910522
AFFX-DapX-5_at
137.5
5.5
0.327079
AFFX-DapX-M_at
205
8.2
0.102165
AFFX-Dr-AB076373-1_at
100
4
0.458816
AFFX-Dr-acta1-3_at
156341.1
6255
0.000219
AFFX-Dr-acta1-5_at
39856.4
1594.6
0.000977
AFFX-Dr-acta1-5_x_at
80275.1
3211.7
0.000219
AFFX-Dr-acta1-M_at
133761
5351.6
0.000219
AFFX-Dr-AF292559-1_at
115
4.6
0.67917
AFFX-Dr-AF292559-2_s_at
15
0.6
0.749276
AFFX-Dr-AF292559-3_s_at
12.5
0.5
0.993468
Total number of rows:
15617
Table truncated, full table size
562 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|